The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.
 

SKP  SKYEPHARMA PLC  ORD 100P

SKYEPHARMA  Currency GBX  Premium Equity Commercial Companies
Company



Price +/- Var % Volume Last close
54.75 0.00 +0.00% - 54.75 on 17-Jun-2013

Bid Offer Trading status
- - No Active Session
High Low Special conditions
- - NONE
As at 18-Jun-2013 07:37:41 -  All data delayed by at least 15 minutes.

Latest news
Select source

Trading Information
18-Jun-2013
FTSE index FTSE Fledgling,FTSE techMARK Focus,FTSE Fledgling (ex IT),FTSE techMARK mediscience,FTSE techMARK All-Share
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Pharmaceuticals
Country of share register GB
Segment SET3
MiFID Status Regulated Market
Exchange market size 3,000
SEDOL B3BFNB6
ISIN number GB00B3BFNB64

Last 5 trades
Time/Date Price Volume Trade value Type
15:17:14  17-Jun-13 56.00 25,000 14,000.00 OK
12:42:28  17-Jun-13 54.33 1,522 826.90 O
12:41:41  17-Jun-13 55.00 15,000 8,250.00 O
11:36:57  17-Jun-13 53.10 500 265.50 O
16:12:08  14-Jun-13 52.29 9,000 4,706.32 O

Fundamentals
Content provided by Morningstar
Key Fundamentals 31-Dec-12 31-Dec-11 31-Dec-10 31-Dec-09 31-Dec-08
Revenue (£ m)   49.90 55.20 58.10 55.90 62.20
Pre-Tax (£ m)   -10.40 -1.00 6.50 -0.90 -28.10
EPS  1.10p 1.90p 29.60p 0.00p -1.70p
PE  65.00 18.82 1.06 n/a -82.06
PEG  -1.54 -0.20 0.00 n/a 1.82
EPS Growth  -42.11% -93.58% 2959900.00% -100.06% -45.16%
Dividend Cover  n/a n/a n/a n/a n/a
Dividend Yield  0.00% 0.00% 0.00% 0.00% 0.00%


Company Information
Updated Monthly
Company address 46-48 Grosvenor Gardens, London, SW1W 0EB, United Kingdom
Company website http://www.skyepharma.com
Market cap(in millions)* £ 25.25
Listing/Admission to trading 03 May 1996
Trading service SETS
Market MAINMARKET
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

SKYEPHARMA price

The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds